Higher SARS-CoV-2 Shedding in Exhaled Aerosol Probably Contributed to the Enhanced Transmissibility of Omicron BA.5 Subvariant
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Respiratory Pathogen Coinfection During Intersecting COVID-19 and Influenza Epidemics.
Jiang L, Jin Y, Li J, Zhang R, Zhang Y, Cheng H Pathogens. 2025; 13(12.
PMID: 39770372 PMC: 11678382. DOI: 10.3390/pathogens13121113.
References
1.
Phan T, Boes S, McCullough M, Gribschaw J, Marsh J, Harrison L
. Emergence of SARS-CoV-2 Omicron BA.5 variant of concern in Western Pennsylvania, United States. J Med Virol. 2022; 94(10):4593-4594.
PMC: 9349382.
DOI: 10.1002/jmv.27945.
View
2.
Zhang Y, Li J, Jiang L, Chen Q, Fu Y, Jin Y
. Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection. J Infect. 2022; 85(2):e37-e39.
PMC: 9158243.
DOI: 10.1016/j.jinf.2022.05.035.
View
3.
Zheng J, Wang Z, Li J, Zhang Y, Jiang L, Fu Y
. High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection. J Infect. 2022; 84(6):e126-e128.
PMC: 8852223.
DOI: 10.1016/j.jinf.2022.02.015.
View
4.
Johnson G, Morawska L
. The mechanism of breath aerosol formation. J Aerosol Med Pulm Drug Deliv. 2009; 22(3):229-37.
DOI: 10.1089/jamp.2008.0720.
View
5.
Desingu P, Nagarajan K
. The emergence of Omicron lineages BA.4 and BA.5, and the global spreading trend. J Med Virol. 2022; 94(11):5077-5079.
PMC: 9349972.
DOI: 10.1002/jmv.27967.
View